This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)

Tipranks - Tue May 12, 7:40AM CDT

Cantor Fitzgerald analyst Sarah James reiterated a Hold rating on Molina Healthcare today and set a price target of $209.00.

Claim 55% Off TipRanks

James covers the Healthcare sector, focusing on stocks such as TruBridge, Acadia Healthcare, and Molina Healthcare. According to TipRanks, James has an average return of 5.7% and a 57.05% success rate on recommended stocks.

In addition to Cantor Fitzgerald, Molina Healthcare also received a Hold from Goldman Sachs’s Scott Fidel in a report issued today. However, on the same day, Bank of America Securities maintained a Buy rating on Molina Healthcare (NYSE: MOH).

Based on Molina Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $10.8 billion and a net profit of $14 million. In comparison, last year the company earned a revenue of $11.15 billion and had a net profit of $298 million

Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is neutral on the stock. Most recently, in March 2026, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.